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ABSTRACT
Objective To describe variation in antibiotic prescribing
for acute cough in contrasting European settings and the
impact on recovery.
Design Cross sectional observational study with
clinicians from 14 primary care research networks in 13
European countries who recorded symptoms on
presentation and management. Patients followed up for
28 days with patient diaries.
Setting Primary care.
Participants Adults with a new or worsening cough or
clinical presentation suggestive of lower respiratory tract
infection.
Main outcome measures Prescribing of antibiotics by
clinicians and total symptom severity scores over time.
Results 3402 patients were recruited (clinicians
completed a case report form for 99% (3368) of
participants and 80% (2714) returned a symptom diary).
Mean symptom severity scores at presentation ranged
from19(scalerange0to100)innetworksbasedinSpain
andItalyto38inthenetworkbasedinSweden.Antibiotic
prescribing by networks ranged from 20% to nearly 90%
(53%overall),withwidevariationinclassesofantibiotics
prescribed. Amoxicillin was overall the most common
antibiotic prescribed, but this ranged from 3% of
antibioticsprescribedintheNorwegiannetworkto83%in
the English network. While fluoroquinolones were not
prescribed at all in three networks, they were prescribed
for18%intheMilannetwork.Afteradjustmentforclinical
presentation and demographics, considerable
differences remained in antibiotic prescribing, ranging
from Norway (odds ratio 0.18, 95% confidence interval
0.11 to 0.30) to Slovakia (11.2, 6.20 to 20.27) compared
with the overall mean (proportion prescribed: 0.53). The
rate of recovery was similar for patients who were and
werenotprescribedantibiotics(coefficient−0.01,P<0.01)
once clinical presentation was taken into account.
Conclusions Variation in clinical presentation does not
explain the considerable variation in antibiotic
prescribing for acute cough in Europe. Variation in
antibiotic prescribing is not associated with clinically
important differences in recovery.
Trial registration Clinicaltrials.gov NCT00353951.
INTRODUCTION
Antibiotic resistance is a growing problem worldwide,
with 10% of Streptococcus pneumoniae isolates recorded
as non-susceptible to penicillin in 30 countries in
2007.
1Thereiswidevariationinantibiotic prescribing
for ambulant patients in Europe.
2 We do not know if
this variation is explained by differences in presenta-
tion of illness or to which conditions it applies. Acute
cough is one of the most common reasons for consult-
ing.TheproportionofEuropeanpatientsconsultingin
general practice with lower respiratory tract infection
who are prescribed antibiotics ranges from about 27%
intheNetherlands(forcoughandbronchitis)to75%in
the United Kingdom.
34 Trial evidence suggests that
mostantibioticprescriptionsdonothelpthesepatients
to get better any quicker, although the datasets are
sometimes small and the impact of case mix at presen-
tation is unclear.
5-7 Variation in antibiotic prescribing
that does not improve outcomes for patients wastes
resources, undermines self care for similar conditions
in the future, puts patients at unnecessary risk of side
effects, and increases selection of resistant organisms,
and so represents an opportunity for improved care
through greater standardisation. Higher levels of pre-
scribing in certain settings, however, might be
explained by differences in severity of illness and so
variation might not always indicate inappropriate pre-
scribing.Weexaminedvariationinantibioticprescrib-
ing for acute cough in primary care in Europe and its
impact on recovery, controlling for presentation.
METHODS
Networks
The Genomics to combat Resistance against Anti-
biotics in Community-acquired lower respiratory
tract infections in Europe (GRACE) (www.grace-lrti.
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researchnetworks(basedinAntwerp,Helsinki,Roten-
burg, Utrecht, Balatonfured, Milan, Tromso, Lodz,
Bratislava, Barcelona, Mataro, Jonkoping, Cardiff,
Southampton) in 13 countries (Belgium, Finland, Ger-
many, Holland, Hungary, Italy, Norway, Poland, Slo-
vakia, Spain (two networks), Sweden, UK (Wales and
England)).
Recruited networks had access to a minimum of
20000 patients and had a track record of conducting
research. A national network coordinator and a
national network facilitator took responsibility
for their network’s set up, recruitment, and data
management.
Study materials and procedures
Study materials (protocol, patient diary, and case
report form) and study procedures were developed
with advice from all networks. The coordinators and
facilitatorsundertookfacetofacetraininginstudypro-
cedures, including entering data on to the GRACE
online system (GOS), and cascaded training to all par-
ticipating general practitioners.
Studydocumentsrequiredbyethicsreviewcommit-
tees and participants (general practitioners and
patients) were translated into local languages.
Back translation by independent translators ensured
accuracy.
Inclusion criteria
Eligiblepatientswere aged18and overwhowere con-
sulting with an illness where an acute or worsened
cough was the main or dominant symptom or had a
clinicalpresentationthatsuggestedalower respiratory
tract infection with a duration of up to and including
28 days, were consulting for the first time within this
illness episode, were seen within normal consulting
hours, had not previously participated in the study,
wereabletofilloutstudymaterials,hadprovidedwrit-
ten informed consent, and were considered immuno-
competent. These broad inclusion criteria captured a
widerangeofpatientswithcommunityacquiredlower
respiratorytractinfection.Althoughalmostallpatients
withthisinfectionhaveacough,theadditionaleligibil-
itycriterionofclinicalpresentationsuggestiveoflower
respiratory tract infection was added to make those
with infection but no cough also eligible.
Recruitment of patients
Participating general practitioners were asked to
recruit consecutive eligible patients in October and
November 2006 and from late January to March
2007. The scheduled two month gap enabled us to
explore the effect of possible temporal variations in
causes of cough during the winter.
Data collection
Clinicians (general practitioners and nurse practi-
tioners) recorded aspects of patients’ history, symp-
toms, comorbidities (diabetes, chronic lung disease,
andcardiovasculardisease),clinicalfindings,andman-
agement, including antibiotic prescription and other
treatments and investigations, on a case report form.
They indicated the presence or absence of 14 symp-
toms (cough, phlegm production, shortness of breath,
wheeze, coryza, fever during this illness, chest pain,
muscle aching, headache, disturbed sleep, feeling gen-
erally unwell, interference with normal activities, con-
fusion/disorientation, and diarrhoea) and then rated
whether each of the symptoms constituted “no pro-
blem,”“ mild problem,”“ moderate problem,” or a
“severe problem” for the patient. The colour of any
sputumproducedwasrecordedasclear,white,yellow,
green, or bloodstained.
Clinicians recorded the patient’s body temperature
with a disposable thermometer (TempaDot, 3M
Health Care) provided in each individual patient
study pack.
Patient reported follow-up
Patientsweregivenasymptomdiary.Theywereasked
to rate 13 symptoms each day until recovery (or for
28 days if symptoms were ongoing) on a seven point
scale from “normal/not affected” to “as bad as it can
be.”Patientsratedthesamesymptomsastheclinicians
apart from confusion/disorientation and diarrhoea. In
addition they were asked to rate the impact of their ill-
ness on their social activities. There were questions
aboutsmokingandcourseoftheillness,includingsub-
sequent management and contacts with the health ser-
vice over the next 28 days.
Data management
All data from case report forms and patients’ diaries
were entered via a remote secure data entry portal
onto the GRACE online system that was compliant
with regulatory guidelines. Central and internal mon-
itoring and checking ensured the accuracy of data col-
lection and entry. Patients were telephoned four to
seven days after inclusion to provide them with the
Patients recruited (n=3402)
Eligible patients (n=3398)
Returned case report forms 
(n=3368, 99%)
No missing data
(n=3296, 97%)
Returned diaries 
(n=2714, 80%)
Returned both case report form and diary (n=2690, 79%)
No missing data (n=2560, 75%)
Fig 1 | Patient flow chart
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with diary completion.
Sample size
Sample size estimation was based on an estimate of a
probabilityof 50%for certaineventssuch astreatment
decisions (50% is the most conservative estimate of
probabilities in statistical terms; more common or
more rare events would give more power). This
required a total sample size of 270 per network to
give 95% confidence intervals of 44 to 56 around
detecting that 50% probability within each network.
Though we had no information on the likely level of
clusteringofantibioticprescribingwithindifferentnet-
works, we considered that this conservative approach
to estimation would give enough power for analyses
between networks while accounting for clustering.
Symptom scores
Thecategoriesforclinicianstoratetheseverityofeach
symptom as “no problem,”“ mild problem,”“ moder-
ate problem,”or “severeproblem” were scored 1,2, 3,
and 4,respectively.Scores were calculatedforpatients
with a minimum of 85% (that is, 12 out of 14 symp-
toms) of their symptoms recorded. This score was
scaled to range between 0 and 100 so that it could be
interpreted as a percentage of maximum symptom
severity.
Wecalculatedpatients’selfreporteddailysymptom
severity scores from the diary data, with scores for 13
symptomssummedandscaledtorangebetween0and
100sothatthesymptomseverityscoreforagivenindi-
vidualona givendaycouldbeinterpretedasapercen-
tage of maximum possible symptom severity. This
daily symptomseverityscore was usedas the outcome
variable in patient outcome model.
Analysis
Descriptives—Descriptive statistics by network and
overall were calculated by using means and standard
deviations (SD), medians (interquartile ranges), and
proportions as appropriate. Presented SDs were
inflated for clustering.
8
Antibiotic prescribing—Differences in clinical presen-
tation were controlled for by using 13 of the 14 symp-
toms recorded by clinicians (cough was excluded as it
was present in 99.8% of cases), sputum type, tempera-
ture, age,and comorbidities. Antibioticprescribing by
networks was investigated by using a two level hier-
archical logistic model
9 fitted to the data from the
casereportformswithpatientsnestedwithinclinicians.
The dependentvariable waswhether the clinician pre-
scribedantibioticsornot,withpatientswhoweregiven
a prescription and advised to delay taking the anti-
biotics counted as receiving a prescription. Network
was included as a fixed effect, with all networks being
compared with the overall mean. The impact of smok-
ing status and durationof illness before consulting was
explored in the subset of patients with complete data
(diary responders).
Patients’ recovery—A three level hierarchical ARMA
(1,1) model
10 was fitted to the logged daily symptom
scores reported by patients (box). We controlled for
differencesinclinicalpresentationusingthesamevari-
ables as in the previous model, along with smoking
status and duration of illness before consulting. We
included the impact of differences in antibiotic man-
agement as both a main effect and an interaction with
time (toallowfordifferentrecoveryrates overtime for
those with and without antibiotics).
ARMA model used to assess variation in outcome in
relation to antibiotic prescribing
An ARMA (1,1) model comprises an autoregressive part
and a moving average part and expresses each
observation as a combination of the two:
Xt=εt+Xt−1+εt−1
where Xt is the symptom severity score at time t, εt is the
e r r o rt e r m .T h i sa l l o w sf o re a c hi n d i v i d u a l ’ss y m p t o m
severity scores and the related error term to be correlated
with the previous day.
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were performed with SPSS version 14.0 (Chicago,
ILL). All modelling was performed in the R program-
ming language and environment
11 using the lme4
12
and nlme
13 packages.
RESULTS
Patients
A total of 3402 patients were recruited by 387 practi-
tioners. Six networks included 270 patients or more,
and all included over 100 (table 1). Four patients
were later found to be ineligible and were excluded
from further analysis. Case report forms were com-
pleted for 3368 (99%) and diary data were obtained
from 2714 (80%) patients. Exclusion of patients with
missing data reduced the case report form dataset to
3296 (97%) and the diary dataset to 2560 (75%)
(fig 1). Those who filled in the diary tended to be
older than those who did not (median age 45
(interquartile range 33-58) v 36 (27-48)). There were
no significant differences in the proportions by sex.
There was some variation in the response rates from
each network, with patients from Eastern European
networks being most likely to return the symptom
diary. Those who did not fill in a diary were no more
or less likely to have been prescribed antibiotics than
the others.
The median age of patients was 45.0 (interquartile
range 35-58), 37% (1228) were men, 98% (3309) were
seen at the office or surgery, 15% (515) had an existing
respiratory condition, 8% (266) had a cardiovascular
related illness, and 4% (138) had diabetes (table 1).
The three most common presenting symptoms, other
thancough(99.7%,3358),werebeinggenerallyunwell
(80%, 2698), phlegm production (77%, 2592), and
interference with normal activities (69%, 2335). The
median number of symptoms recorded by a clinician
was eight (6-9). Patients were unwell before the
Table 1 |Countries, networks, general practitioners, practices, and included patients
Site
Patients/
practices/
clinicians Men*
Age
(years)†
Symptom
sever-
ity†‡
Oral temperature*§ Comorbidity*¶
Antibiotic
treatment
Duration
of course
(days)† Low Normal High R H D
Belgium
Antwerp 216/18/26 46.80 (101) 47 (36-60) 31 (21-40) 19.70 (42) 62.90 (134) 17.40 (37) 23.60 (51) 8.30 (18) 3.70 (8) 25.90% (56) 8 (7-8)
Finland
Helsinki 103/2/26 24.30 (25) 45 (34-56) 31 (24-43) 17.50 (18) 76.70 (79) 5.80 (6) 13.60 (14) 2.90 (3) 2.90 (3) 41.70% (43) 9 (7-10)
Germany
Rotenberg 229/16/16 31.00 (71) 40 (29-52) 33 (24-43) 28.50 (65) 65.40 (149) 16.10 (14) 15.30 (35) 7.90 (18) 4.40 (10) 34.50% (79) 7 (6-7)
Holland
Utrecht 200/11/34 44 (88) 57 (42-67) 33 (24-43) 28.50 (57) 68.50 (137) 3.00 (6) 27.00 (54) 15 (30) 7.50 (15) 41.50% (83) 7 (7-7)
Hungary
Balaton-
fured
323/11/11 39.90 (129) 42 (29-53) 26 (17-36) 11.50 (37) 51.10 (165) 37.50 (121) 9.30 (30) 9.00 (29) 4.00 (13) 74.60% (241) 5 (5-7)
Italy
Milan 207/13/12 33.30 (69) 43 (36-58) 19 (12-29) 13.50 (28) 79.20 (164) 7.20 (15) 12.60 (26) 7.20 (15) 2.90 (6) 74.90% (155) 7 (5-7)
Norway
Tromso 203/11/41 36.50 (74) 50 (37-57) 36 (26-43) 21.40 (42) 70.90 (139) 7.70 (15) 22.70 (46) 7.40 (15) 5.40 (11) 30% (203) 10 (7-10)
Poland
Lodz 301/9/21 30.60 (92) 40 (28-55) 36 (26-45) 33.20 (100) 52.50 (158) 14.30 (43) 13.30 (40) 19.90 (60) 2.70 (8) 71.40% (215) 7 (5-7)
Slovakia
Bratislava 299/5/23 33.10 (99) 41 (30-52) 26 (19-36) 2.70 (8) 71.80 (209) 25.40 (74) 13.00 (39) 17.10 (51) 3.30 (10) 87.60% (262) 7 (7-7)
Spain
Barcelona 277/3/25 33.60 (93) 43 (29-59) 19 (14-29) 20.70 (57) 72.40 (199) 6.90 (19) 9.40 (26) 3.60 (10) 3.60 (10) 20.60% (57) 8 (6-8)
Mataro 196/3/21 39.80 (78) 46 (33-64) 19 (13-29) 24.50 (48) 70.90 (139) 4.60 (9) 16.80 (33) 10.20 (20) 5.60 (11) 34.20% (67) 8 (5-8)
Sweden
Jonkoping 300/12/81 36.70 (110) 47.5 (37-61) 38 (29-49) 18.90 (56) 70.70 (210) 10.40 (31) 16.00 (48) 5.30 (16) 3.30 (10) 38% (114) 9 (9-10)
UK
Cardiff 300/5/26 38.30 (115) 45 (34-59) 36 (24-45) 21.30 (64) 74.30 (223) 4.30 (13) 26 (78) 8.00 (24) 5.00 (15) 69.70% (209) 7 (5-7)
Southamp-
ton
214/6/23 39.30 (84) 49 (36-
59.75)
36 (26-43) 10.90 (23) 82.50 (174) 6.60 (14) 20.60 (44) 9.30 (20) 3.70 (8) 62.60% (214) 7 (7-7)
Total 3368/125/
387
36.50
(1228/
3368)
45 (33-58) 31 (19-40) 19.30 (645) 68.20
(2279)
12.50 (417) 15.30
(515)
7.90 (266) 4.10 (138) 52.70%
(1776)
7 (6-7)
*Percentage (number).
†Median (interquartile range).
‡Score scaled to range between 0 and 100.
§Low (<36°c), normal (≥36°c and ≤37.2°c), high (>37.2°c).
¶R=respiratory illness (chronic obstructive pulmonary disease (COPD), asthma, other lung disease); H=heart disease (heart failure, ischaemic heart disease, other heart disease); D=diabetes.
RESEARCH
page 4 of 8 BMJ | ONLINE FIRST | bmj.comconsultation for a median of five days (3-8). The aver-
age temperature was 36.8ºC (SD 1.59).
Antibiotic prescribing
Antibioticswereprescribedfor53%(1776)ofincluded
patients for a median of seven days (6-7) (table 1).
There were notable differences between networks in
the unadjusted proportion of patients who were pre-
scribed antibiotics. Clinicians from networks based in
Bratislava, Milan, Balatonfured, Lodz, and Cardiff
weremorelikelytoprescribeantibioticsthantheover-
all average.
Amoxicillinaccountedfor29%ofprescriptions,ran-
ging from 3% in Tromso to 83% in the Southampton
network (fig 2). Macrolides/lincosamides were pre-
scribedfor26%ofpatients,rangingfrom4%inUtrecht
to 50%, 45%, and 38% in the Bratislava, Milan, and
Lodz networks, respectively. Co-amoxiclav was pre-
scribed for 15%, though this varied widely, from 0%
in Jonkoping and Tromso to 47% in Barcelona (it was
the most commonly prescribed antibiotic in both Bar-
celona and Mataro (43%)). Tetracyclines were pre-
scribed for 14%. Three networks did not prescribe
tetracyclines at all (Barcelona, Mataro, and Milan),
and they were the first choice in three networks
(Utrecht 72%, Jonkoping 56%, and Helsinki 51%).
Cephalosporins were prescribed for 7% (ranging
from 0% to 13%) and fluoroquinolones for 5%. Fluor-
oquinolones were most commonly prescribed in the
Milan, Mataro, and Balatonfured networks (18%,
16%, and 13%, respectively) and were not prescribed
at all in six networks (Southampton, Barcelona, Lodz,
Jonkoping, Tromso, and Helsinki).
Antibiotic prescribing by networks adjusted for clinical
presentation
Significant variation between networks remained after
adjustment for clinical presentation, with antibiotic
prescribing in 11 networks significantly different
from the overall mean at the 5% level (table 2). Figure
3 shows the unadjusted and adjusted odds ratios for
antibiotic prescribing for all networks.
There were no significant differences between the
two recruitment periods in overall rate of antibiotic
prescribing. The model was also fitted to the subsam-
pleofpatientswithusablediarydatatochecktheeffect
of duration of illness before consultation and smoking
statusonprescribing.Bothvariablesweresignificantly
associatedwith receiving a prescription for antibiotics,
witha2%increaseintheoddsofreceivinganantibiotic
for each additional day of illness before consulting
(odds ratio 1.02, 95% confidence interval 1.01 to
1.04) and a 38% increase in the odds for smokers
(1.38, 1.09 to 1.76). Adjustment for these factors, how-
ever, had no effect on the magnitude or significance of
the variation between networks and therefore we have
presented the model with the larger sample.
Patients’ recovery
Therewasconsiderablevariationbetweennetworksin
therateofrecoveryafterpresentation,asshownbythe
median symptom trajectory plots (fig 4). The median
time to patients reporting feeling recovered (single
item)was11days.Themediantimeforpatients’symp-
tom severity scores to drop to 0 was 15 days. Respira-
tory comorbidity was associated with initial higher
symptom severity scores. Those who waited longer
before presenting had higher initial symptom severity
scores.
Significant variation in outcome remained across
networks after adjustment for clinical presentation,
with two of the networks (Balatonfured and Mataro)
reporting differences in patients’ reported symptom
severity at baseline compared with the overall mean,
threenetworks(Cardiff,Milan,andJonkoping)report-
ing significantly slower recovery rates, and three net-
works (Mataro, Balatonfured, Antwerp) reporting
Table 2 |Two level logistic regression model* of odds of being prescribed antibiotic in each
network (3296 patients from 384 clinicians). Figures are odds ratios (95% confidence
intervals)
Network OR (95% CI) P value
Antwerp 0.22 (0.12 to 0.38) <0.001
Balatonfured 5.69 (2.88 to 11.26) <0.001
Barcelona 0.29 (0.16 to 0.51) <0.001
Bratislava 11.2 (6.20 to 20.27) <0.001
Cardiff 2.44 (1.42 to 4.19) <0.01
Helsinki 0.58 (0.31 to 1.09) 0.09
Jonkoping 0.25 (0.16 to 0.38) <0.001
Lodz 4.14 (2.4 to 7.16) <0.001
Mataro 0.66 (0.37 to 1.18) 0.16
Milan 6.81 (3.49 to 13.27) <0.001
Rotenberg 0.5 (0.27 to 0.92) 0.03
Southampton 0.84 (0.47 to 1.5) 0.55
Tromso 0.18 (0.11 to 0.30) <0.001
Utrecht 0.5 (0.29 to 0.85) 0.01
*Model controls for clinician rated symptom scores and clinical presentation. Clinician level variance component
was 23.3%, using π
2/3 estimator.
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cant differences in the symptom trajectories across the
networks, differences were not large. Almost all the
symptom trajectories converged after a week (fig 5).
Being prescribed antibiotics was associated with a fas-
ter reduction in symptom severity scores, as indicated
bythesignificantinteractionbetweenprescribinganti-
biotics and day. This association, however, was small
(table 3).
The impact of antibiotic prescribing, while statisti-
cally significant, represents a tenth of a single percen-
tage difference in symptom severity score (not
presented), and therefore it is reasonable to consider
it clinically unimportant. Such a small effect is entirely
consistent with a placebo effect.
Hospital admission
Overall,1.1%(28)ofpatientswereadmittedtohospital
after inclusion. For individual networks this ranged
from none to 4.3% (9).
DISCUSSION
Main findings
In this large prospective international comparative
studyofthe managementofacutecoughamongadults
in primarycare we found considerable variationin the
13 countries studied. Major differences in the decision
whether or not to prescribe an antibiotic in these set-
tings remained, even after we adjusted for clinical pre-
sentation(symptoms,durationofillness,smoking,age,
comorbidity, and temperature). Patients included by
networks based in Bratislava, Milan, Balatonfured,
Lodz, and Cardiff were at least twice as likely to be
prescribed antibiotics than the overall mean. Patients
included by networks based in Tromso, Antwerp, and
Jonkoping were at least four times less likely to be pre-
scribed antibiotics than the overall mean.
We also identified marked differences between net-
works in choice of antibiotic. For example, while
amoxicillin was overall the most common antibiotic
prescribed, this ranged from 3% in the Tromso net-
workto83%inSouthampton.Whilefluoroquinolones
were prescribed for 5% overall, they were prescribed
for 18% of patients included in the Milan network.
These differences might be attributable to different
guidelines and habits in different countries. This will
be further explored in a parallel qualitative study.
There were two main findings regarding patients’
recovery. Firstly, there were significant differences
between networks in both severity of symptoms on
day one (intercept) and the recovery rate (slope). Dif-
ferences in the recovery rate, however, were small
(fig 5), and patients recovered at a similar rate regard-
less of network. Secondly, whether a patient was pre-
scribed antibiotics or not was statistically associated
with outcome. The magnitude of this association
amounted to a difference of a tenth of a single per
cent in the symptom severity score after seven days,
which is not clinically relevant.
Strengths and limitations
Weprospectivelydescribedantibioticprescribingfora
welldefinedpopulationofpatientsinalargenumberof
countries recruited at the same time. Recruitment was
for two periods over a single winter, and findings by
recruitment period were similar, suggesting local or
temporal variations in cause were unlikely to have
explained the observed differences.
The clinicians who participated (and therefore their
patients)wereallaffiliatedtoaresearchnetworkandso
might not have been representative. In general,
research minded clinicians might be more likely to
practice according to guidelines.
14 They would have
been aware of our interest in exploring international
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Fig 5 | Predicted recovery curves by network for those
prescribed antibiotics from ARMA model
Table 3 |Estimates for ARMA (1,1) model*: symptom severity scores over time (65 541
observations in 2560 patients from 364 clinicians)
Parameter estimate, P value Interactions with time, P value
Management
Prescribed antibiotics 0.05, 0.26 −0.01, <0.01
Network
Antwerp 0.05, 0.52 -0.01, 0.03
Balatonfured -0.27, <0.001 -0.01, 0.02
Barcelona -0.07, 0.32 0.00, 0.84
Bratislava -0.04, 0.50 -0.00, 0.29
Cardiff 0.09, 0.17 0.01, 0.02
Helsinki 0.03, 0.72 0.00, 0.62
Jonkoping 0.02, 0.78 0.01, <0.001
Lodz -0.05, 0.38 -0.01, 0.07
Mataro 0.28, <0.001 -0.02, <0.001
Milan -0.13, 0.08 0.01, <0.01
Rotenberg 0.02, 0.77 0.00, 0.98
Southampton 0.01, 0.90 0.01, 0.08
Tromso 0.11, 0.14 0.00, 0.42
Utrecht -0.05, 0.52 0.00, 0.88
*Model controls for clinician recorded symptom scores and clinical presentation as well as allowing recovery
trajectory to follow cubic polynomial.
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led to an underestimation of the differences we found.
Bias
As the study spanned 13 European countries, there is
no guarantee that perceptions of health and reporting
of symptoms were consistent. We do not know how
cultural differences influenced our results. We are
exploring these issues in a parallel qualitative study
with patients and clinicians in nine of the networks.
Response bias was not relevant to data from the case
reportformsastherewasa99%completionrate.Com-
pletion rates for patients’ diaries ranged from 60% in
the Cardiff network to almost 100% in the Bratislava
network. The overall response rate to the diary was
high (80%). Non-responders might have deteriorated
more than responders, but given similar rates of anti-
bioticprescribingbetweenthetwogroupsandthegen-
erally benign natural clinical course of this condition
thisisunlikely.Ascertainmentbiaswasminimisedbya
data collection protocol used by all networks. While
every network followed this protocol, some networks
implemented additional strategies to improve diary
return rates. The impact of different intensities of con-
tact with patients during follow-up is uncertain.
Sample size
This international study was adequately powered to
explore antibiotic prescribing. Only a small number
of patients were admitted to hospital, and there were
no deaths. While this reflects the natural course of
acute cough and the fact that it is managed almost
exclusively in primary care, the low number of such
complications made Europe-wide comparisons on
admission to hospital impossible. For the analysis of
recovery, the combination of the large number of
data points per patient with the large number of
patients made this analysis overpowered with some
significant findings having little or no clinical rele-
vance.
Comparison with previous studies
A study of antibiotic treatment for lower respiratory
tract infection in France, Germany, Italy, Spain, and
the UK over 10 years ago asked general practitioners
to retrospectively describe their management of cases.
Overall, community acquired pneumonia accounted
for 18% of cases, making this a highly unusual sample.
Retrospective data collection carries particular risks of
selection bias and incomplete ascertainment of com-
parable clinical data. Overall, 83% were prescribed
antibiotics.
15
In a two country comparison, general practitioners
in Spain and Denmark recorded their management of
respiratory tract infections. Spanish general practi-
tioners prescribed more antibiotics for patients with a
presumed tonsillar and bronchi/lung infection focus.
There was no adjustment for severity and duration of
illness or smoking.
16
Implications for practice and research
Some interventions have been shown to successfully
reduce inappropriate antibiotic prescribing in general
practice,
17-21 and prescribing fewer antibiotics at the
general practice level is associated with local reduc-
tions in antibiotic resistance.
22
We identified marked differences in whether and
what antibiotics are prescribed for acute cough
throughout Europe that remained after adjustment
forclinicalpresentationbasedontheclinician’sassess-
ment of symptoms, duration of illness, smoking,
patient’s history (the presence of any comorbidities),
age, and temperature.
Wealsofoundthatlargedifferencesinantibioticpre-
scribing did not translate to clinically important differ-
ences in patients’ recovery. Therefore management of
acute cough is an issue that is appropriate for standar-
dised international care pathways promoting conser-
vative antibiotic prescribing.
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